Purchase Order 75F40125P00027

Award Date 1/7/25
Potential Completion Date 1/13/26
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for $7,590.78 to provide preventative maintenance services for an Attune Acoustic Focusing Flow Cytometer. The contract does not have a set-aside designation. As a manufacturer of scientific instruments, reagents, and consumables, Life Technologies serves as a prime contractor across various federal agencies, including the NIH,...
This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and...
This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for DNA analysis equipment and services. The $585,136.93 Firm Fixed Price contract was awarded by the Defense Health Agency and has a completion date of January 3, 2025. The contract is a Blanket Purchase Agreement (BPA) call order, indicating it is part of a larger indefinite delivery vehicle. Life Technologies has been awarded multiple federal contracts and grant sub-awards,...
The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis...
This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the purchase of an inverted light microscope and objectives valued at $12,857.95. The award was made by the Food and Drug Administration (FDA), a civilian federal agency. The contract is a firm fixed-price purchase order with a completion date of June 20, 2013. It does not have a set-aside designation. Life Technologies has been awarded multiple contracts and subcontracts across various...
This is a federal contract award from the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for $95,672.40 to provide genetic analyzer corrective/remedial repair and preventive maintenance services. The contract has a period of performance through February 9, 2022 and is a firm fixed price purchase order. There is no set-aside designation. Life Technologies has established itself as a prime contractor across multiple federal...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
This is a $82,231.05 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The award is for an Automated Express Nucleic Acid Extraction System, which supports the FDA's mission in medical research, disease prevention, and healthcare. The contract has no set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools to...
The U.S. Food and Drug Administration (FDA) awarded a $87,843.87 firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, to provide preventative and corrective maintenance services for 7,500 real-time PCR systems over a 4-year period ending on August 31, 2025. This award was not set aside for any small business program. The original solicitation, FDA_21-223-1236746, was posted on November 10, 2020 with a due date of...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs...

This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the maintenance, repair, and service of ATTUNE NXT with Autosampler flow cytometry equipment. The $11,052.99 firm fixed price contract has a completion date of January 13, 2026 and was awarded by the Food and Drug Administration (FDA), a civilian agency, on January 7, 2025. This award is not associated with a set-aside or larger contract vehicle. Life Technologies is a leading provider of biomedical research and genetic analysis tools to government agencies, and has previously supported the FDA, National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs through similar contract and grant awards for specialized equipment, reagents, and services.

Generated 1/8/25, 9:21 AM